Diagnosi del carcinoma prostatico: Stato dell'arte

Translated title of the contribution: Diagnosis of prostate cancer: State of the art

M. Roscigno, V. Scattoni, R. Bertini, A. Pasta, F. Montorsi, P. Rigatti

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

The widespread acceptance of prostate-specific antigen (PSA) measurement as an early detection method for prostate cancer (Pca), coupled with the recent heightened public awarness of Pca as a common disease, has led to an increase in the detection of Pca. It has been established that digital rectal examination (DRE) and PSA are the most useful front-line methods for assessing an individual's risk of Pca. In addition to an elevated PSA above 4 ng/mL and an abnormal DRE, the decision to proceed with TRUS-guided biopsy may also be supported by other factors. Determining the presence of a significant rise in PSA between tests, whether the degree of PSA is concordant with the size of the prostate, and age appropriate PSA may aid in the interpretation of this risk. Grayscale transrectal ultrasound (TRUS) has been established as the first choice imaging technique making it possible to take biopsies, measure the volume and obtain a general overview of the prostate. To improve, however, the TRUS detection rate of Pca, many ultrasonographic technique improvements have been introduced and continuously evaluated. As for prostate biopsy, in the prostate with visible lesions, lesion-guided biopsies only play a role in combination with systematic biopsies, while the systematic prostate biopsy scheme should at the present time include 10 or 12 cores according to prostatic weight. The other imaging techniques actually play a marginal role in Pca detection, but may be useful for staging newly diagnosed Pca or in patient re-staging in case of biochemical failure after radical treatment.

Original languageItalian
Pages (from-to)123-145
Number of pages23
JournalMinerva Urologica e Nefrologica
Volume56
Issue number2
Publication statusPublished - Jun 2004

Fingerprint

Prostate-Specific Antigen
Prostatic Neoplasms
Prostate
Biopsy
Digital Rectal Examination
Weights and Measures

ASJC Scopus subject areas

  • Nephrology
  • Urology

Cite this

Roscigno, M., Scattoni, V., Bertini, R., Pasta, A., Montorsi, F., & Rigatti, P. (2004). Diagnosi del carcinoma prostatico: Stato dell'arte. Minerva Urologica e Nefrologica, 56(2), 123-145.

Diagnosi del carcinoma prostatico : Stato dell'arte. / Roscigno, M.; Scattoni, V.; Bertini, R.; Pasta, A.; Montorsi, F.; Rigatti, P.

In: Minerva Urologica e Nefrologica, Vol. 56, No. 2, 06.2004, p. 123-145.

Research output: Contribution to journalArticle

Roscigno, M, Scattoni, V, Bertini, R, Pasta, A, Montorsi, F & Rigatti, P 2004, 'Diagnosi del carcinoma prostatico: Stato dell'arte', Minerva Urologica e Nefrologica, vol. 56, no. 2, pp. 123-145.
Roscigno M, Scattoni V, Bertini R, Pasta A, Montorsi F, Rigatti P. Diagnosi del carcinoma prostatico: Stato dell'arte. Minerva Urologica e Nefrologica. 2004 Jun;56(2):123-145.
Roscigno, M. ; Scattoni, V. ; Bertini, R. ; Pasta, A. ; Montorsi, F. ; Rigatti, P. / Diagnosi del carcinoma prostatico : Stato dell'arte. In: Minerva Urologica e Nefrologica. 2004 ; Vol. 56, No. 2. pp. 123-145.
@article{02f284a49ffb4640aaf84571d3ee8f92,
title = "Diagnosi del carcinoma prostatico: Stato dell'arte",
abstract = "The widespread acceptance of prostate-specific antigen (PSA) measurement as an early detection method for prostate cancer (Pca), coupled with the recent heightened public awarness of Pca as a common disease, has led to an increase in the detection of Pca. It has been established that digital rectal examination (DRE) and PSA are the most useful front-line methods for assessing an individual's risk of Pca. In addition to an elevated PSA above 4 ng/mL and an abnormal DRE, the decision to proceed with TRUS-guided biopsy may also be supported by other factors. Determining the presence of a significant rise in PSA between tests, whether the degree of PSA is concordant with the size of the prostate, and age appropriate PSA may aid in the interpretation of this risk. Grayscale transrectal ultrasound (TRUS) has been established as the first choice imaging technique making it possible to take biopsies, measure the volume and obtain a general overview of the prostate. To improve, however, the TRUS detection rate of Pca, many ultrasonographic technique improvements have been introduced and continuously evaluated. As for prostate biopsy, in the prostate with visible lesions, lesion-guided biopsies only play a role in combination with systematic biopsies, while the systematic prostate biopsy scheme should at the present time include 10 or 12 cores according to prostatic weight. The other imaging techniques actually play a marginal role in Pca detection, but may be useful for staging newly diagnosed Pca or in patient re-staging in case of biochemical failure after radical treatment.",
keywords = "Biopsy, Prostate specific antigen, Prostatic neoplasms, diagnosis, Ultrasonography",
author = "M. Roscigno and V. Scattoni and R. Bertini and A. Pasta and F. Montorsi and P. Rigatti",
year = "2004",
month = "6",
language = "Italian",
volume = "56",
pages = "123--145",
journal = "Minerva Urologica e Nefrologica",
issn = "0393-2249",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "2",

}

TY - JOUR

T1 - Diagnosi del carcinoma prostatico

T2 - Stato dell'arte

AU - Roscigno, M.

AU - Scattoni, V.

AU - Bertini, R.

AU - Pasta, A.

AU - Montorsi, F.

AU - Rigatti, P.

PY - 2004/6

Y1 - 2004/6

N2 - The widespread acceptance of prostate-specific antigen (PSA) measurement as an early detection method for prostate cancer (Pca), coupled with the recent heightened public awarness of Pca as a common disease, has led to an increase in the detection of Pca. It has been established that digital rectal examination (DRE) and PSA are the most useful front-line methods for assessing an individual's risk of Pca. In addition to an elevated PSA above 4 ng/mL and an abnormal DRE, the decision to proceed with TRUS-guided biopsy may also be supported by other factors. Determining the presence of a significant rise in PSA between tests, whether the degree of PSA is concordant with the size of the prostate, and age appropriate PSA may aid in the interpretation of this risk. Grayscale transrectal ultrasound (TRUS) has been established as the first choice imaging technique making it possible to take biopsies, measure the volume and obtain a general overview of the prostate. To improve, however, the TRUS detection rate of Pca, many ultrasonographic technique improvements have been introduced and continuously evaluated. As for prostate biopsy, in the prostate with visible lesions, lesion-guided biopsies only play a role in combination with systematic biopsies, while the systematic prostate biopsy scheme should at the present time include 10 or 12 cores according to prostatic weight. The other imaging techniques actually play a marginal role in Pca detection, but may be useful for staging newly diagnosed Pca or in patient re-staging in case of biochemical failure after radical treatment.

AB - The widespread acceptance of prostate-specific antigen (PSA) measurement as an early detection method for prostate cancer (Pca), coupled with the recent heightened public awarness of Pca as a common disease, has led to an increase in the detection of Pca. It has been established that digital rectal examination (DRE) and PSA are the most useful front-line methods for assessing an individual's risk of Pca. In addition to an elevated PSA above 4 ng/mL and an abnormal DRE, the decision to proceed with TRUS-guided biopsy may also be supported by other factors. Determining the presence of a significant rise in PSA between tests, whether the degree of PSA is concordant with the size of the prostate, and age appropriate PSA may aid in the interpretation of this risk. Grayscale transrectal ultrasound (TRUS) has been established as the first choice imaging technique making it possible to take biopsies, measure the volume and obtain a general overview of the prostate. To improve, however, the TRUS detection rate of Pca, many ultrasonographic technique improvements have been introduced and continuously evaluated. As for prostate biopsy, in the prostate with visible lesions, lesion-guided biopsies only play a role in combination with systematic biopsies, while the systematic prostate biopsy scheme should at the present time include 10 or 12 cores according to prostatic weight. The other imaging techniques actually play a marginal role in Pca detection, but may be useful for staging newly diagnosed Pca or in patient re-staging in case of biochemical failure after radical treatment.

KW - Biopsy

KW - Prostate specific antigen

KW - Prostatic neoplasms, diagnosis

KW - Ultrasonography

UR - http://www.scopus.com/inward/record.url?scp=3843139312&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3843139312&partnerID=8YFLogxK

M3 - Articolo

C2 - 15195022

AN - SCOPUS:3843139312

VL - 56

SP - 123

EP - 145

JO - Minerva Urologica e Nefrologica

JF - Minerva Urologica e Nefrologica

SN - 0393-2249

IS - 2

ER -